Patients will be recruited with active RA:
* The ACR/EULAR classification for a diagnosis of RA could have been at any time in the patient’s disease history; the score does not need to be 6 or more at screening.
** Current NICE guidelines available at the following link: http://www.nice.org.uk/guidance/ta375
Patients will be excluded if they have any contraindication to Etanercept, Rituximab or Tocilizumab therapy:
This study is jointly funded by MRC and ARUK | Copyright © Experimental Medicine & Rheumatology Department, Queen Mary University London, 2014 - 2022